Cyrus T - Search Results

1

Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor.

Zhao L, Ding T, Cyrus T, Cheng Y, Tian H, Ma M, Falotico R, Praticò D. Zhao L, et al. Among authors: cyrus t. Br J Pharmacol. 2009 Mar;156(5):774-85. doi: 10.1111/j.1476-5381.2008.00080.x. Epub 2009 Feb 13. Br J Pharmacol. 2009. PMID: 19220291 Free PMC article.

2

Effect of low-dose aspirin on vascular inflammation, plaque stability, and atherogenesis in low-density lipoprotein receptor-deficient mice.

Cyrus T, Sung S, Zhao L, Funk CD, Tang S, Praticò D. Cyrus T, et al. Circulation. 2002 Sep 3;106(10):1282-7. doi: 10.1161/01.cir.0000027816.54430.96. Circulation. 2002. PMID: 12208806

3

Vitamin E reduces progression of atherosclerosis in low-density lipoprotein receptor-deficient mice with established vascular lesions.

Cyrus T, Yao Y, Rokach J, Tang LX, Praticò D. Cyrus T, et al. Circulation. 2003 Feb 4;107(4):521-3. doi: 10.1161/01.cir.0000055186.40785.c4. Circulation. 2003. PMID: 12566360

4

Involvement of thromboxane receptor in the proatherogenic effect of isoprostane F2alpha-III: evidence from apolipoprotein E- and LDL receptor-deficient mice.

Tang M, Cyrus T, Yao Y, Vocun L, Praticò D. Tang M, et al. Among authors: cyrus t. Circulation. 2005 Nov 1;112(18):2867-74. doi: 10.1161/CIRCULATIONAHA105.562223. Circulation. 2005. PMID: 16267259

5

Thromboxane receptor blockade improves the antiatherogenic effect of thromboxane A2 suppression in LDLR KO mice.

Cyrus T, Yao Y, Ding T, Dogné JM, Praticò D. Cyrus T, et al. Blood. 2007 Apr 15;109(8):3291-6. doi: 10.1182/blood-2006-08-044990. Epub 2006 Dec 7. Blood. 2007. PMID: 17158227 Free PMC article.

6

A novel thromboxane receptor antagonist and synthase inhibitor, BM-573, reduces development and progression of atherosclerosis in LDL receptor deficient mice.

Cyrus T, Yao Y, Ding T, Dogné JM, Praticò D. Cyrus T, et al. Eur J Pharmacol. 2007 Apr 30;561(1-3):105-11. doi: 10.1016/j.ejphar.2006.12.024. Epub 2007 Jan 19. Eur J Pharmacol. 2007. PMID: 17306791

7

Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein e-deficient mice.

Cyrus T, Praticò D, Zhao L, Witztum JL, Rader DJ, Rokach J, FitzGerald GA, Funk CD. Cyrus T, et al. Circulation. 2001 May 8;103(18):2277-82. doi: 10.1161/01.cir.103.18.2277. Circulation. 2001. PMID: 11342477

8

Lipid peroxidation and platelet activation in murine atherosclerosis.

Cyrus T, Tang LX, Rokach J, FitzGerald GA, Praticò D. Cyrus T, et al. Circulation. 2001 Oct 16;104(16):1940-5. doi: 10.1161/hc4101.097114. Circulation. 2001. PMID: 11602498

9

Endogenous biosynthesis of thromboxane and prostacyclin in 2 distinct murine models of atherosclerosis.

Praticò D, Cyrus T, Li H, FitzGerald GA. Praticò D, et al. Among authors: cyrus t. Blood. 2000 Dec 1;96(12):3823-6. Blood. 2000. PMID: 11090066 Free article.

10

Stabilization of advanced atherosclerosis in low-density lipoprotein receptor-deficient mice by aspirin.

Cyrus T, Yao Y, Tung LX, Praticò D. Cyrus T, et al. Atherosclerosis. 2006 Jan;184(1):8-14. doi: 10.1016/j.atherosclerosis.2004.10.047. Epub 2005 Apr 25. Atherosclerosis. 2006. PMID: 16326168

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters